Holen Sie sich die Stockscreener-App
39.73
1.51%
-0.61
Handel nachbörslich:
39.89
0.16
+0.40%
Schlusskurs vom Vortag:
$40.34
Offen:
$37.79
24-Stunden-Volumen:
1.76M
Relative Volume:
1.95
Marktkapitalisierung:
$2.05B
Einnahmen:
$412.82M
Nettoeinkommen (Verlust:
$-8.19M
KGV:
-257.82
EPS:
-0.1541
Netto-Cashflow:
$64.17M
1W Leistung:
+39.35%
1M Leistung:
+69.21%
6M Leistung:
+98.55%
1J Leistung:
+236.41%
1-Tages-Spanne:
$37.74
$40.47
1-Wochen-Bereich:
$27.68
$40.47
52-Wochen-Spanne:
$11.26
$40.47
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
39.73 | 2.08B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
CareDx CEO John Hanna sells $4.46m in company stock - Investing.com
Form 4 Caredx Inc For: 17 July By Investing.com - Investing.com Canada
[Form 4] CareDx, Inc. Insider Trading Activity - Stock Titan
CareDx (CDNA) director sells 28,779 shares and exercises options - Stock Titan
H.C. Wainwright reiterates Neutral stock rating on CareDx By Investing.com - Investing.com Canada
CareDx (CDNA) Moves 35.6% Higher: Will This Strength Last? - Yahoo Finance
CareDx rallies after Medicare finalizes transplant testing coverage policy - MSN
CareDx says final Medicare LCD maintains coverage for transplant rejection surveillance tests - Bitget
CareDx sets webcast to discuss second-quarter 2026 results after market close - Bitget
BTIG raises CareDx stock price target to $45 on coverage decision By Investing.com - Investing.com South Africa
Price to earnings forward of CareDx, Inc. – GETTEX:1K9 - TradingView
CareDx Inc. (CDNA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
CareDx (CDNA) Jumps As Naveris Deal Redraws Growth Map - timothysykes.com
Form 144 CAREDX For: 16 July By Investing.com - Investing.com Canada
CDNA (NASDAQ: CDNA) holder John Hanna files notice to sell 118,000 shares - Stock Titan
Planned 28,779-share CDNA (NASDAQ: CDNA) sale follows earlier 10b5-1 trade - Stock Titan
Caredx Inc stock hits 52-week high at 36.4 USD By Investing.com - Investing.com South Africa
CAREDX INC : BTIG RAISES TARGET PRICE TO $45 FROM $28 - Bitget
CareDx shares jump as Medicare finalizes transplant testing coverage policy (CDNA) - MSN
CDNA Maintained by BTIG -- Price Target Raised to $45 - GuruFocus
Why Is CareDx Stock Skyrocketing Thursday? - Benzinga
BTIG raises CareDx stock price target to $45 on coverage decision - Investing.com Canada
Caredx Inc stock hits 52-week high at 36.4 USD - Investing.com
CareDx to report Q2 2026 financial results on July 30 - scanx.trade
CareDx (CDNA) Secures Medicare Coverage for Molecular Testing - GuruFocus
CareDx stock surges 20% on Medicare coverage policy By Investing.com - Investing.com India
CareDx stock surges 20% on Medicare coverage policy - Investing.com
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 - Business Wire
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination - Business Wire
How Caredx Inc. (CDNA) Affects Rotational Strategy Timing - Stock Traders Daily
CareDx (CDNA) Following Reimbursement Progress Is The Stock Starting To Look Fully Valued - Sahm
Price to earnings forward of CareDx, Inc. – LSX:A118WG - TradingView
Frontier tech research, news & data - MLQ.ai
CareDx to Participate in Upcoming Investor Conferences - AOL.com
Form 4 Caredx Inc For: 7 July By Investing.com - Investing.com Nigeria
CareDx (CDNA) director receives 1,746-share quarterly stock grant as compensation - Stock Titan
CareDx (CDNA) exits lab products and acquires Naveris to expand $12B market - Stock Titan
CareDx Completes Naveris Acquisition and Expands Oncology Reach - Yahoo Finance
CareDx: The Transplant Platform Is Becoming A Specialty Diagnostics Compounder (CDNA) - Seeking Alpha
Diagnostic Co.'s Oversight Reforms Deal Gets Final OK - Law360
Form 4 Caredx Inc For: 6 July By Investing.com - Investing.com Nigeria
CareDx (CDNA) CEO has 8,511 shares withheld for RSU tax obligations - Stock Titan
CareDx Leaders’ Audit Reforms Settlement Gets Court Approval (1) - Bloomberg Law News
CareDx Deadline Alert - TMX Newsfile
Enterprise value to EBITDA forward of CareDx, Inc. – NASDAQ:CDNA - TradingView
CareDx Inc (CDNA) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CDNACaredx Inc Short Interest - Finviz
CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology - Yahoo Finance
CareDx Inc. (CDNA) Holds Steady Near Resistance as Consolidation ContinuesSystematic Flow - dars.gov.et
CareDx (CDNA) general counsel has 997 shares withheld for tax obligations - Stock Titan
CareDx (CDNA) CCO has shares withheld to cover taxes on RSU vesting - Stock Titan
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.61%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):